Related Experiment Videos
Mucinic tumor markers recognized by monoclonal antibodies
E Seregni1, E Bombardieri, L Maffioli
1Divisione di Medicina Nucleare, Istituto Nazionale Tumori, Milan, Italy.
The Journal of Nuclear Medicine and Allied Sciences
|October 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pilot scale validation campaign of gel dosimetry for pre-treatment quality assurance in stereotactic radiotherapy.
Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2023
Radioembolization of hepatocarcinoma with 90Y glass microspheres: treatment optimization using the dose-toxicity relationship.
European journal of nuclear medicine and molecular imaging·2020
Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle.
Journal of experimental & clinical cancer research : CR·2019
An improved automated one-pot synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) based on a purification by cartridges.
Nuclear medicine and biology·2019
Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies.
Journal of endocrinological investigation·2018
[Increased levels of Ca 19-9, Ca 50 and Ca 125 in patients with benign diseases of the biliary tract and the pancreas].
The Journal of nuclear medicine and allied sciences·1990
[Prognostic significance of macrophage infiltration in laryngeal carcinoma].
The Journal of nuclear medicine and allied sciences·1990
Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.
JTO clinical and research reports·2026
Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
B-cells in breast cancer: current insights and challenges.
Frontiers in oncology·2026
The heterogeneous and dynamic immune-tumor interface in breast cancer.
Frontiers in oncology·2026